文献速递妇科生殖医学

BRCA1/2携带者与妇科医生对胚胎植入前及产前遗传检测的态度

Reproductive Decision-Making Among BRCA1/2 Pathogenic Variants Carriers and Physicians: Attitudes Toward Preimplantation and Prenatal Genetic Testing.
PubMed 文献 · Prenat Diagn · 2026-03-02

该研究通过结构化问卷调查了89名BRCA1/2致病变异携带者和37名妇科医生对单基因病胚胎植入前遗传检测(PGT-M)和产前诊断(PND)的认知、态度与伦理顾虑。结果显示,获知信息前仅28%携带者了解PGT-M和PND,获知后多数认为应作为标准生殖咨询内容(PGT-M 87.6%,PND 85.7%),但医生认知不一致且常规讨论较少,86.5%临床医生呼吁更清晰指南和多学科协作。

要点

  • 获知信息前仅28%的BRCA携带者了解PGT-M和PND。
  • 获知后87.6%和85.7%的携带者分别认为应讨论PGT-M和PND。
  • 妇科医生对BRCA携带者的PGT-M和PND认知分别为45.9%和51.4%。

核心结论

  • BRCA携带者的生殖意愿与医疗专业人员的实践和知识之间存在差距。
  • 弥合该差距需要教育、指南制定和多学科生殖咨询。

研究设计与样本

  • 采用结构化问卷的调查研究。
  • 纳入89名BRCA1/2携带者和37名妇科医生,评估认知、态度和伦理顾虑。

主要发现

  • 获知信息前仅28%的携带者了解PGT-M和PND。
  • 获知后多数携带者认为应向所有BRCA突变携带者讨论这些选项(PGT-M 87.6%,PND 85.7%)。
  • 携带者仍存在对激素刺激、终止妊娠和伦理影响的顾虑。
  • 妇科医生对PGT-M和PND的认知不一致(45.9%和51.4%),且很少常规与患者讨论。
  • 86.5%的临床医生表示需要更清晰的指南和多学科协作。

关键数值与推荐

  • 获知信息前携带者对PGT-M和PND的认知率为28%。
  • 携带者认为应讨论PGT-M的比例为87.6%,应讨论PND的比例为85.7%。
  • 妇科医生对BRCA携带者PGT-M的认知率为45.9%,对PND的认知率为51.4%。
  • 86.5%的临床医生需要更清晰指南和多学科协作。

临床怎么用

  • 应将PGT-M和PND纳入BRCA携带者的标准生殖咨询。
  • 需提升妇科医生对BRCA携带者生殖遗传检测选项的认知和常规讨论。
  • 开展教育并制定清晰指南,采用多学科协作进行生殖咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this paper is to investigate the knowledge and attitudes of BRCA1/2 pathogenic variant carriers and gynecologists regarding preimplantation genetic tests for monogenic diseases (PGT-M) and prenatal diagnosis (PND). METHODS: A survey using structured questionnaires was completed by 89 BRCA1/2 carriers and 37 gynecologists, assessing awareness, attitudes, and ethical concerns. RESULTS: Before receiving information, only 28% of carriers were aware of PGT-Mand PND. Once informed, the majority believed that these options should be discussed with all BRCA mutation carriers as part of standard reproductive counseling (87.6% for PGT-M and 85.7% for PND). Many indicated a willingness to consider their use. Nonetheless, concerns remained, particularly regarding hormonal stimulation, pregnancy termination, and ethical implications. Among gynecologists, awareness of PGT-M and PND as options for BRCA carriers was inconsistent (45.9% and 51.4%, respectively), and few routinely discussed these options with patients. Ethical concerns were common, and 86.5% of clinicians expressed the need for clearer guidelines and multidisciplinary collaboration. CONCLUSION: The findings reveal a discrepancy between reproductive preferences of BRCA mutation carriers and current practices and knowledge among healthcare professionals. Bridging this gap will require educational efforts, development of guidelines, and a multidisciplinary approach to reproductive counseling in the context of hereditary cancer risk.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. D'Alonzo M, Actis S, Lavalle G, et al. Reproductive Decision-Making Among BRCA1/2 Pathogenic Variants Carriers and Physicians: Attitudes Toward Preimplantation and Prenatal Genetic Testing. Prenat Diagn. 2026. PMID: 41772393. doi:10.1002/pd.70111

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。